CYTEK BIOSCIENCES INC (CTKB)

US23285D1090 - Common Stock

6.83  +0.26 (+3.96%)

After market: 6.83 0 (0%)

CYTEK BIOSCIENCES INC

NASDAQ:CTKB (1/3/2025, 8:00:01 PM)

After market: 6.83 0 (0%)

6.83

+0.26 (+3.96%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS SubIndustryLife Sciences Tools & Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%1100%
Sales Q2Q%7.29%
CRS69.86
6 Month21.96%
Overview
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)N/A N/A
Ins Owners8.62%
Inst Owners58.68%
Market Cap879.77M
Shares128.81M
PEN/A
Fwd PE115.45
Dividend YieldN/A
Analysts80
Short Float %3.15%
Short Ratio5.26
IPO07-23 2021-07-23
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

CTKB Daily chart

Company Profile

Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. The company is headquartered in Fremont, California and currently employs 645 full-time employees. The company went IPO on 2021-07-23. The firm is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion reagent cocktail preparation system; the flow cytometer and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels beyond 40 biomarkers.

Company Info

CYTEK BIOSCIENCES INC

47215 Lakeview Boulevard

Fremont CALIFORNIA

P: 18779229835

Employees: 645

Website: https://cytekbio.com

CTKB News

News Image2 days ago - Cytek Biosciences, Inc.Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

FREMONT, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the...

News Image5 days ago - Cytek Biosciences, Inc.Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
News Image5 days ago - Cytek Biosciences, Inc.Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025...

News Image2 months ago - Cytek Biosciences, Inc.Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

FREMONT, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the...

News Image2 months ago - Cytek Biosciences, Inc.Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
News Image2 months ago - Cytek Biosciences, Inc.Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

Cytek Biosciences has been named “Overall BioTech Company of the Year” in the fourth annual BioTech Breakthrough Awards program. ...

CTKB Twits

Here you can normally see the latest stock twits on CTKB, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example